Literature DB >> 25093884

The global intellectual property landscape of induced pluripotent stem cell technologies.

MacKenna Roberts1, Ivan B Wall2, Ian Bingham3, Dominic Icely3, Brock Reeve4, Kim Bure5, Anna French6, David A Brindley7.   

Abstract

Mesh：

Year:  2014        PMID： 25093884     DOI： 10.1038/nbt.2975

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  15 in total

Review 1.  Recalibrating intellectual property rights to enhance translational research collaborations.

Authors:  Tania Bubela; Garret A FitzGerald; E Richard Gold
Journal:  Sci Transl Med       Date:  2012-02-22       Impact factor: 17.956

2.  Pluripotent patents make prime time: an analysis of the emerging landscape.

Authors:  Brenda M Simon; Charles E Murdoch; Christopher T Scott
Journal:  Nat Biotechnol       Date:  2010-06       Impact factor: 54.908

3.  Embryonic stem cell trials for macular degeneration: a preliminary report.

Authors:  Steven D Schwartz; Jean-Pierre Hubschman; Gad Heilwell; Valentina Franco-Cardenas; Carolyn K Pan; Rosaleen M Ostrick; Edmund Mickunas; Roger Gay; Irina Klimanskaya; Robert Lanza
Journal:  Lancet       Date:  2012-01-24       Impact factor: 79.321

4.  The global stem cell patent landscape: implications for efficient technology transfer and commercial development.

Authors:  Karl Bergman; Gregory D Graff
Journal:  Nat Biotechnol       Date:  2007-04       Impact factor: 54.908

5.  Opening stem cell research and development: a policy proposal for the management of data, intellectual property, and ethics.

Authors:  David E Winickoff; Krishanu Saha; Gregory D Graff
Journal:  Yale J Health Policy Law Ethics       Date:  2009

6.  Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds.

Authors:  Pingping Hou; Yanqin Li; Xu Zhang; Chun Liu; Jingyang Guan; Honggang Li; Ting Zhao; Junqing Ye; Weifeng Yang; Kang Liu; Jian Ge; Jun Xu; Qiang Zhang; Yang Zhao; Hongkui Deng
Journal:  Science       Date:  2013-07-18       Impact factor: 47.728

7.  The gold rush for induced pluripotent stem cells.

Authors:  Sarah Webb
Journal:  Nat Biotechnol       Date:  2009-11       Impact factor: 54.908

8.  Japan to offer fast-track approval path for stem cell therapies.

Authors:  David Cyranoski
Journal:  Nat Med       Date:  2013-05       Impact factor: 53.440

9.  Access to stem cells and data: persons, property rights, and scientific progress.

Authors:  Debra J H Mathews; Gregory D Graff; Krishanu Saha; David E Winickoff
Journal:  Science       Date:  2011-02-11       Impact factor: 47.728

10.  Induced pluripotent stem cell lines derived from human somatic cells.

Authors:  Junying Yu; Maxim A Vodyanik; Kim Smuga-Otto; Jessica Antosiewicz-Bourget; Jennifer L Frane; Shulan Tian; Jeff Nie; Gudrun A Jonsdottir; Victor Ruotti; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2007-11-20       Impact factor: 47.728
View more
  5 in total

1.  21(st) Century Cures Act: An Act of Cure or Diagnosis?

Authors:  David A Brindley; Zeeshaan Arshad; Dee Luo; Sue Dopson; Georg Hollander; Stephen Frost; Chas Bountra; James A Smith
Journal:  Rejuvenation Res       Date:  2015-08       Impact factor: 4.663

2.  Patent mining and landscaping of emerging recombinant factor VIII through network analysis.

Authors:  Cristiano Gonçalves Pereira; Virgínia Picanco-Castro; Dimas Tadeu Covas; Geciane Silveira Porto
Journal:  Nat Biotechnol       Date:  2018-07-06       Impact factor: 54.908

Review 3.  Patent Application Trends of Induced Pluripotent Stem Cell Technologies in the United States, Japanese, and European Applications.

Authors:  Yasushi Morita; Hanayuki Okura; Akifumi Matsuyama
Journal:  Biores Open Access       Date:  2019-03-19

Review 4.  Therapeutic Use of Mesenchymal Stromal Cells: The Need for Inclusive Characterization Guidelines to Accommodate All Tissue Sources and Species.

Authors:  Adrienne Wright; Marne L Arthaud-Day; Mark L Weiss
Journal:  Front Cell Dev Biol       Date:  2021-02-16

Review 5.  Secreted trophic factors of mesenchymal stem cells support neurovascular and musculoskeletal therapies.

Authors:  Heidi R Hofer; Rocky S Tuan
Journal:  Stem Cell Res Ther       Date:  2016-09-09       Impact factor: 6.832
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.